Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects

Clinical trial NCT02513654 · COMPLETED

Trial details

NCT number: NCT02513654
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2015-09-06
Primary completion: 2015-11-11
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.